Tag Archives: patents

BIO Provides Supplemental Comments on PTO s.101 Guidelines

Posted on October 21, 2014 by Warren Woessner

BIO recently generated a letter to the PTO on the March 6th Guidelines on the patent-eligibility of subject matter in the life sciences, particularly “natural products.” BIO invited a group of in-house and private practitioners to comment on the Guidelines … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged bio, biotechnology, biotechnology law, Patent Law, patents, USPTO, Warren Woessner | Leave a comment

“The Good Wife” Defends GMOs

Posted on October 7, 2014 by Warren Woessner

Last Sunday’s episode of “The Good Wife” featured a Christian mediation between a farmer (Robert Joy) sued by a Pioneer-like company, represented by the actor Richard Thomas, for saving GMO corn seed for replanting. The facts were a mash-up of … Continue reading →

Posted in Ag Biotechnology, Patent Eligible Subject Matter | Tagged Bioagriculture, biotechnology, biotechnology law, GMO, intellectual property, ip, Patent Law, patents, The Good Wife, Warren Woessner | Leave a comment

Australia: Cancer Voices v Myriad Opinion Affirmed

Posted on September 5, 2014 by Warren Woessner

This is a guest post from Paul Cole. An opinion was handed down earlier today by the Federal Court of Australia – Full Court (Allsop C.J., Downsett, Kenny, Bennett and Middleton J.J., D’Arcy v Myriad Genetics Inc [2014] FCAFC 115 … Continue reading →

Posted in EP and UK Practice | Tagged biotechnology law, EPO, intellectual property, ip, Myriad, Patent Law, patents, Paul Cole, Warren Woessner | 2 Comments

101 Rejections Under the Guidelines: Mayo and Myriad “Go Viral”

Posted on September 4, 2014 by Warren Woessner

This is a guest post from Hans Sauer, Deputy General Counsel, Intellectual Property for BIO. “Recently, I set out to find real-world examples of recent rejections under the USPTO Guidance, to do my own sampling rather than rely on reported … Continue reading →